A case report of duodenal perforation caused  by imatinib mesylate during adjuvant treatment of gastric stromal tumor.

This study reported that imatinib mesylate caused bowel perforation in one patient with gastric stromal tumors after its use for 3 months. PMID: 33605877 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research